GLY 202
Alternative Names: GLY-202Latest Information Update: 13 Jan 2023
At a glance
- Originator Glycan Therapeutics
- Class Hepatoprotectants; Small molecules
- Mechanism of Action HMGB1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Liver disorders